// App-Quantinova.ai

: Pegylated Interferon induced Latent Autoimmune Diabetes Mellitus of Adults(LADA) in acute setting is not uncommon

Researchers

Presenter

  • Gideon Mlawa

Principal Investigators

  • Chrisopher Smith

  • Janessa Bell

  • Hassan Rehmani

  • Mahamud Bashir

  • Shrini Patel

  • Haythum Elsayed

  • Muhammad Saleem

  • Musarat Hussain

Medical Centers

  • Guy's Hospital, London, United Kingdom

  • Queen`s Hospital, Diabetes and Endocrinology/Acute Medicine, London, United Kingdom

  • Queen’s Hospital, Acute Medicine, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Central Nervous System (CNS)

  • Oncology (ONC)

  • Cardiovascular (CVS)

  • Endocrine/metabolic Diseases (ME)

Disease

  • Type 1 diabetes mellitus

  • Coronary Artery Disease

  • Diabetes

  • Polycythemia vera

  • Stroke

Biomarkers

  • Hemoglobin A1c

  • Insulin

  • Interferon-alpha

  • Interferon

Drug/Treatment

  • Pegylated interferon alpha

  • Peginterferon alfa-2a

  • Interferon alpha

  • Insulin detemir

  • Adianor

  • Interferon

  • Metformin Hydrochloride

  • IFN-lambda

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved